Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4110982 | 0.81 | — | — | |
| SCHEMBL672872 | 0.77 | CYP2C19 (0.39) | — | |
| SCHEMBL9297095 | 0.74 | — | — | |
| SCHEMBL28995193 | 0.72 | — | — | |
| SCHEMBL17334223 | 0.70 | GAA (0.41) | — | |
| SCHEMBL11322416 | 0.70 | — | — | |
| SCHEMBL1966296 | 0.69 | CYP2C19 (0.30) | — | |
| SCHEMBL11319614 | 0.69 | — | — | |
| SCHEMBL1562915 | 0.67 | — | — | |
| SCHEMBL9329687 | 0.65 | ALDH1A1 (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2881198-B1 | PROCESS FOR PRODUCING COATED FINE SILVER PARTICLES AND PASTE COMPRISING SAID COATED FINE SILVER PARTICLES | UNIV YAMAGATA NAT UNIV CORP (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-20150231698-A1 | PROCESS FOR PRODUCING COATED SILVER FINE PARTICLES AND COATED SILVER FINE PARTICLES PRODUCED BY SAID PRODUCTION PROCESS | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) | 2015-08-20 | — | — | US | disclosed |
| EP-2881198-A1 | PROCESS FOR PRODUCING COVERED SILVER FINE PARTICLES AND COVERED SILVER FINE PARTICLES PRODUCED BY SAID PROCESS | National University Corporation Yamagata University (JP) | 2015-06-10 | — | — | EP | disclosed |
| US-20090247488-A1 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | CANNIZZARO CARINA | 2009-10-01 | — | — | US | disclosed |
| US-20090227543-A1 | PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY | CANNIZZARO CARINA | 2009-09-10 | — | — | US | disclosed |
| US-7470724-B2 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. (US) | 2008-12-30 | — | — | US | disclosed |
| US-7432261-B2 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-20060199788-A1 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. | 2006-09-07 | — | — | US | disclosed |
| EP-1663254-A2 | ANTI-INFLAMATORY PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060035866-A1 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. | 2006-02-16 | — | — | US | disclosed |
| EP-1620110-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004100960-A2 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004096236-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| US-4165411-A | HYDROPHILIC POLYETHERURETHANE FOAM CONTAINING ALUMINA HYDRATE AND A PHOSPOROUS-CONTAINING MATERIAL | W. R. GRACE & CO. (US) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035866-A1 | Phosphonate compounds having immuno-modulatory activity | PHOSPHO1, NFATC1, IFNG | ALDH1A1 4028/4885 |
| US-20090227543-A1 | PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY | PHOSPHO1, NFATC1, IFNG | ALDH1A1 4028/4885 |
| US-20090247488-A1 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | PHOSPHO1, TNF, PTGES | ALDH1A1 3467/4885 |
| US-20060199788-A1 | Anti-inflammatory phosphonate compounds | PHOSPHO1, TNF, PTGES | ALDH1A1 3467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.